Loading...

Milestone Scientific

AMEX:MLSS
Snowflake Description

Excellent balance sheet with concerning outlook.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MLSS
AMEX
$13M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The last earnings update was 9 days ago. More info.


Add to Portfolio Compare Print
  • Milestone Scientific has significant price volatility in the past 3 months.
MLSS Share Price and Events
7 Day Returns
-7.9%
AMEX:MLSS
-0.3%
US Medical Equipment
0.2%
US Market
1 Year Returns
-64.5%
AMEX:MLSS
10.1%
US Medical Equipment
2.9%
US Market
MLSS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Milestone Scientific (MLSS) -7.9% -19.5% -3.2% -64.5% -86.3% -83.7%
US Medical Equipment -0.3% 3.2% -1% 10.1% 55.2% 90.1%
US Market 0.2% -1.6% 2.4% 2.9% 36.1% 41%
1 Year Return vs Industry and Market
  • MLSS underperformed the Medical Equipment industry which returned 10.1% over the past year.
  • MLSS underperformed the Market in United States of America which returned 2.9% over the past year.
Price Volatility
MLSS
Industry
5yr Volatility vs Market

MLSS Value

 Is Milestone Scientific undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Milestone Scientific. This is due to cash flow or dividend data being unavailable. The share price is $0.33.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Milestone Scientific's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Milestone Scientific's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
AMEX:MLSS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $-0.17
AMEX:MLSS Share Price ** AMEX (2019-05-23) in USD $0.33
United States of America Medical Equipment Industry PE Ratio Median Figure of 64 Publicly-Listed Medical Equipment Companies 38.96x
United States of America Market PE Ratio Median Figure of 3,085 Publicly-Listed Companies 17.79x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Milestone Scientific.

AMEX:MLSS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= AMEX:MLSS Share Price ÷ EPS (both in USD)

= 0.33 ÷ -0.17

-1.91x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Milestone Scientific is loss making, we can't compare its value to the US Medical Equipment industry average.
  • Milestone Scientific is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Milestone Scientific's expected growth come at a high price?
Raw Data
AMEX:MLSS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.91x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
89.1%per year
United States of America Medical Equipment Industry PEG Ratio Median Figure of 55 Publicly-Listed Medical Equipment Companies 2.15x
United States of America Market PEG Ratio Median Figure of 2,123 Publicly-Listed Companies 1.54x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Milestone Scientific, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Milestone Scientific's assets?
Raw Data
AMEX:MLSS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $0.07
AMEX:MLSS Share Price * AMEX (2019-05-23) in USD $0.33
United States of America Medical Equipment Industry PB Ratio Median Figure of 182 Publicly-Listed Medical Equipment Companies 4.48x
United States of America Market PB Ratio Median Figure of 5,201 Publicly-Listed Companies 1.84x
AMEX:MLSS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= AMEX:MLSS Share Price ÷ Book Value per Share (both in USD)

= 0.33 ÷ 0.07

4.87x

* Primary Listing of Milestone Scientific.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Milestone Scientific is overvalued based on assets compared to the US Medical Equipment industry average.
X
Value checks
We assess Milestone Scientific's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Milestone Scientific has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

MLSS Future Performance

 How is Milestone Scientific expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
89.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Milestone Scientific expected to grow at an attractive rate?
  • Unable to compare Milestone Scientific's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare Milestone Scientific's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.
  • Milestone Scientific's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
Raw Data
AMEX:MLSS Future Growth Rates Data Sources
Data Point Source Value (per year)
AMEX:MLSS Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 89.1%
AMEX:MLSS Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 17.5%
United States of America Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.9%
United States of America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 8.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.7%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
AMEX:MLSS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
AMEX:MLSS Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 13 -1 1
2019-12-31 9 -3 1
AMEX:MLSS Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 10 -1 -6
2018-12-31 10 -2 -7
2018-09-30 8 -2 -9
2018-06-30 9 -2 -6
2018-03-31 9 -1 -7
2017-12-31 11 -1 -5
2017-09-30 11 -3 -5
2017-06-30 11 -3 -6
2017-03-31 11 -5 -6
2016-12-31 10 -5 -6
2016-09-30 11 -3 -6
2016-06-30 11 -4 -5

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Milestone Scientific is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • Milestone Scientific's revenue is expected to grow by 17.5% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
AMEX:MLSS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Milestone Scientific Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

AMEX:MLSS Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 -0.02 -0.02 -0.02 1.00
2019-12-31 -0.07 -0.07 -0.07 1.00
AMEX:MLSS Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 -0.17
2018-12-31 -0.21
2018-09-30 -0.27
2018-06-30 -0.19
2018-03-31 -0.20
2017-12-31 -0.16
2017-09-30 -0.16
2017-06-30 -0.18
2017-03-31 -0.19
2016-12-31 -0.22
2016-09-30 -0.23
2016-06-30 -0.24

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Milestone Scientific will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Milestone Scientific's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Milestone Scientific has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

MLSS Past Performance

  How has Milestone Scientific performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Milestone Scientific's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Milestone Scientific does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Milestone Scientific's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Milestone Scientific's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Milestone Scientific's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Milestone Scientific Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

AMEX:MLSS Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 9.73 -6.34 9.74 0.03
2018-12-31 9.62 -7.43 10.65 0.25
2018-09-30 8.07 -9.40 11.68 0.25
2018-06-30 9.30 -6.42 11.98 0.28
2018-03-31 9.40 -6.56 12.24 0.39
2017-12-31 11.28 -5.19 11.93 0.27
2017-09-30 10.57 -5.14 11.32 0.76
2017-06-30 10.86 -5.55 11.05 1.04
2017-03-31 10.60 -5.70 11.26 1.23
2016-12-31 10.48 -5.95 11.55 1.27
2016-09-30 11.47 -5.61 11.66 0.81
2016-06-30 10.79 -5.35 11.20 0.52
2016-03-31 10.29 -5.80 10.50 0.23
2015-12-31 9.49 -5.47 9.40 0.10
2015-09-30 9.67 -5.43 9.62 0.06
2015-06-30 9.74 -4.22 8.98 0.07
2015-03-31 10.48 -2.32 7.91 0.08
2014-12-31 10.33 -1.70 7.40 0.09
2014-09-30 10.46 0.69 6.24 0.09
2014-06-30 10.37 1.27 5.72 0.07
2014-03-31 10.14 1.51 5.54 0.09
2013-12-31 10.01 1.46 5.53 0.19
2013-09-30 9.48 0.08 5.65 0.22
2013-06-30 9.17 -0.13 5.72 0.27
2013-03-31 9.22 -0.36 5.87 0.26
2012-12-31 8.65 -0.87 5.93 0.18
2012-09-30 8.12 -0.91 5.65 0.19
2012-06-30 7.74 -1.56 5.96 0.12

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Milestone Scientific has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Milestone Scientific has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Milestone Scientific improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Milestone Scientific's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Milestone Scientific has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

MLSS Health

 How is Milestone Scientific's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Milestone Scientific's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Milestone Scientific is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Milestone Scientific's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Milestone Scientific's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 56.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Milestone Scientific Company Filings, last reported 1 month ago.

AMEX:MLSS Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 2.73 0.13 2.74
2018-12-31 1.53 0.00 0.74
2018-09-30 1.05 0.00 0.41
2018-06-30 5.32 0.00 0.87
2018-03-31 5.95 0.00 2.09
2017-12-31 7.50 0.00 2.64
2017-09-30 9.09 0.00 2.31
2017-06-30 7.66 0.00 2.95
2017-03-31 8.53 0.00 2.94
2016-12-31 8.54 0.00 3.60
2016-09-30 7.22 0.00 2.32
2016-06-30 8.61 0.00 3.18
2016-03-31 8.37 0.00 2.67
2015-12-31 9.17 0.00 4.19
2015-09-30 11.93 0.00 4.39
2015-06-30 13.40 0.00 7.00
2015-03-31 14.80 0.00 9.33
2014-12-31 15.04 0.05 10.37
2014-09-30 15.27 0.00 10.28
2014-06-30 15.31 0.00 10.62
2014-03-31 5.88 0.00 1.40
2013-12-31 5.52 0.05 1.15
2013-09-30 3.79 0.05 0.40
2013-06-30 2.66 0.45 0.17
2013-03-31 2.42 0.45 0.12
2012-12-31 1.94 0.45 0.17
2012-09-30 1.96 0.45 0.27
2012-06-30 1.89 0.45 0.12
  • Milestone Scientific's level of debt (4.8%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0% vs 4.8% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Milestone Scientific has sufficient cash runway for 2.1 years based on current free cash flow.
  • Milestone Scientific has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of -40.2% each year.
X
Financial health checks
We assess Milestone Scientific's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Milestone Scientific has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

MLSS Dividends

 What is Milestone Scientific's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Milestone Scientific dividends.
If you bought $2,000 of Milestone Scientific shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Milestone Scientific's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Milestone Scientific's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
AMEX:MLSS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
United States of America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 24 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2005 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

AMEX:MLSS Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Milestone Scientific has not reported any payouts.
  • Unable to verify if Milestone Scientific's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Milestone Scientific's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Milestone Scientific has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Milestone Scientific's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Milestone Scientific afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Milestone Scientific has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

MLSS Management

 What is the CEO of Milestone Scientific's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Leonard Osser
COMPENSATION $540,484
AGE 71
TENURE AS CEO 1.4 years
CEO Bio

Mr. Leonard A. Osser has been the Interim Chief Executive Officer of Milestone Scientific Inc., since December 18, 2017. Mr. Osser is a Founder of Milestone Scientific Inc. and had been Managing Director of China Operations since July 10, 2017 until December2017. Mr. Osser has been the Interim Chief Executive Officer and Director at Milestone Medical, Inc. since March 2011. He serves as an Advisor at Quark Ventures S.A. and was previously a Member of Advisory Board of the firm. He served as the Chief Executive Officer at Milestone Scientific Inc. from September 2009 to July 10, 2017. He served as an Interim Chief Executive Officer at Milestone Scientific Inc. since March 27, 2009. He served as the Chief Executive Officer at Milestone Scientific Inc. from July 1991 to January 2008. He served as the Chief Executive Officer and Chairman of the Board of Advanced Ocular Sciences S.A. from 1991 to 2007. Mr. Osser served as the President at Spintech since November 1995. Mr. Osser served as Chief Executive Officer at Spintech from November 1995 to January 2008. From 1980 to November 1995, Mr. Osser was a Principal Owner and Chief Executive at U.S. Asian Consulting Group, Inc., where he focused on workout, distressed and turnaround situations in the medical, technology, retailing, resource recovery, and waste disposal and securities industries. In the late 1980s, his work with U.S.-based investment banks and broker-dealers involved him in extensive due diligence and corporate finance work for small to mid-sized companies. He served as Chairman at Milestone Scientific Inc. from July 1991 to September 2009. He has been a Director at Milestone Scientific Inc. since July 1991. He served as a Director of Advanced Ocular Sciences S.A. He developed a computer-controlled system that delivers injections with scientific precision. He has finance and operating management experience with companies worldwide. Mr. Osser has a 28-year career in finance, consulting and operations management for companies around the world.

CEO Compensation
  • Leonard's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Leonard's remuneration is about average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Milestone Scientific management team in years:

2.6
Average Tenure
62
Average Age
  • The tenure for the Milestone Scientific management team is about average.
Management Team

Leonard Osser

TITLE
Founder
COMPENSATION
$540K
AGE
71
TENURE
1.4 yrs

Joseph D'Agostino

TITLE
CFO & COO
COMPENSATION
$225K
AGE
66
TENURE
11.3 yrs

Sharon Smith

TITLE
Executive Vice President of Global Sales & Marketing
COMPENSATION
$284K
TENURE
1.2 yrs

Gian Trombetta

TITLE
President & CEO of Wand Dental Inc. and Director
COMPENSATION
$280K
AGE
57
TENURE
4.6 yrs

James McAvinn

TITLE
Senior Vice President of Sales & Marketing
TENURE
2.6 yrs

Rosaline Shau

TITLE
Vice President and Assistant Controller
AGE
58
Board of Directors Tenure

Average tenure and age of the Milestone Scientific board of directors in years:

4.3
Average Tenure
71
Average Age
  • The tenure for the Milestone Scientific board of directors is about average.
Board of Directors

Leslie Bernhard

TITLE
Chairman of the Board
COMPENSATION
$66K
AGE
74
TENURE
9.6 yrs

Leonard Osser

TITLE
Founder
COMPENSATION
$540K
AGE
71
TENURE
27.8 yrs

Gian Trombetta

TITLE
President & CEO of Wand Dental Inc. and Director
COMPENSATION
$280K
AGE
57
TENURE
5 yrs

Leonard Schiller

TITLE
Independent Director
COMPENSATION
$36K
AGE
77
TENURE
22.1 yrs

Edward Zelnick

TITLE
Independent Director
COMPENSATION
$36K
AGE
72
TENURE
4.3 yrs

Joe Chalil

TITLE
Member of Global Advisory Board
AGE
45
TENURE
3.2 yrs

Zhang Lidong

TITLE
Member of Global Advisory Board
AGE
57
TENURE
3.2 yrs

Michael McGeehan

TITLE
Independent Director
COMPENSATION
$36K
AGE
52
TENURE
1.6 yrs

Neal Goldman

TITLE
Director
AGE
74
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
26. Feb 19 Buy Innovest SpA Company 08. Feb 19 08. Feb 19 714,286 $0.35 $250,000
26. Feb 19 Buy Michael McGeehan Individual 06. Feb 19 06. Feb 19 85,000 $0.35 $29,750
08. Feb 19 Buy Leonard Osser Individual 06. Feb 19 06. Feb 19 285,000 $0.35 $99,750
08. Feb 19 Buy Edward Zelnick Individual 06. Feb 19 06. Feb 19 15,000 $0.35 $5,250
X
Management checks
We assess Milestone Scientific's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Milestone Scientific has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

MLSS News

Simply Wall St News

How Does Investing In Milestone Scientific Inc. (NYSEMKT:MLSS) Impact The Volatility Of Your Portfolio?

Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … Any stock with a beta of greater than one is considered more volatile than the market, while those with a beta below one are either less volatile or poorly correlated with the market. … If this beta value holds true in the future, Milestone Scientific shares are likely to rise more than the market when the market is going up, but fall faster when the market is going down.

Simply Wall St -

Have Insiders Been Buying Milestone Scientific Inc. (NYSEMKT:MLSS) Shares?

The Last 12 Months Of Insider Transactions At Milestone Scientific. … That means that an insider was happy to buy shares at around the current price … In any event it's generally a positive if insiders are buying shares at around the current price.

Simply Wall St -

Is Milestone Scientific, Inc.'s (NYSEMKT:MLSS) Balance Sheet A Threat To Its Future?

(NYSEMKT:MLSS), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. … Is financial flexibility worth the lower cost of capital. … There are well-known benefits of including debt in capital structure, primarily a lower cost of capital

Simply Wall St -

Does Milestone Scientific Inc (NYSEMKT:MLSS) Have A Volatile Share Price?

In finance, Beta is a measure of volatility. … Beta is a widely used metric to measure a stock's exposure to market risk (volatility). … Before we go on, it's worth noting that Warren Buffett pointed out in his 2014 letter to shareholders that 'volatility is far from synonymous with risk.' Having said that, beta can still be rather useful.

Simply Wall St -

Who Really Owns Milestone Scientific Inc (NYSEMKT:MLSS)?

In this article, I will take a quick look at Milestone Scientific Inc’s (NYSEMKT:MLSS) recent ownership structure – an unconventional investing subject, but an important one. … Ownership structure of a company has been found to affect share performance over time. … Therefore, it is beneficial for us to examine MLSS's ownership structure in more detail.

Simply Wall St -

Milestone Scientific Inc (NYSEMKT:MLSS): Risks You Need To Consider Before Buying

The other type of risk, which cannot be diversified away, is market risk. … Every stock in the market is exposed to this risk, which arises from macroeconomic factors such as economic growth and geo-political tussles just to name a few. … A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one.

Simply Wall St -

Is It The Right Time To Buy Milestone Scientific Inc (NYSEMKT:MLSS)?

Milestone Scientific Inc (NYSEMKT:MLSS), a medical equipment company based in United States,. … As a small cap stock, hardly covered by any analysts, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value? … Let’s take a look at Milestone Scientific’s outlook and value based on the most recent financial data to see if the opportunity still exists

Simply Wall St -

Loss-Making Milestone Scientific Inc (NYSEMKT:MLSS) Expected To Breakeven

With the latest financial year loss of -US$5.19m and a trailing-twelve month of -US$6.56m, the US$26.91m market-cap amplifies its loss by moving further away from its breakeven target? … View out our latest analysis for Milestone Scientific … MLSS is bordering on breakeven, according to Medical Equipment analysts.

Simply Wall St -

Interested In Milestone Scientific Inc (NYSEMKT:MLSS)? Here's How It Performed Recently

See our latest analysis for Milestone Scientific Were MLSS's earnings stronger than its past performances and the industry? … AMEX:MLSS Income Statement Mar 28th 18 We can further analyze Milestone Scientific's loss by looking at what the industry has been experiencing over the past few years. … Each year, for the past five years Milestone Scientific's top-line has grown by a mere 4.14%, on average.

Simply Wall St -

What Does Milestone Scientific Inc's (NYSEMKT:MLSS) Share Price Indicate?

Milestone Scientific Inc (AMEX:MLSS), a medical equipment company based in United States, saw a decent share price growth in the teens level on the AMEX over the last few months. … The stock’s ratio of 4.28x is currently trading slightly above its industry peers’ ratio of 3.78x, which means if you buy Milestone Scientific today, you’d be paying a relatively fair price for it. … And if you believe Milestone Scientific should be trading in this range, then there isn’t really any room for the share price grow beyond what it’s currently trading.

Simply Wall St -

MLSS Company Info

Description

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.

Details
Name: Milestone Scientific Inc.
MLSS
Exchange: AMEX
Founded: 1989
$13,471,387
40,822,387
Website: http://www.milesci.com
Address: Milestone Scientific Inc.
220 South Orange Avenue,
Livingston,
New Jersey, 07039,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
AMEX MLSS Common Stock NYSE MKT LLC US USD 03. Nov 1995
Number of employees
Current staff
Staff numbers
16
Milestone Scientific employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/23 23:40
End of day share price update: 2019/05/23 00:00
Last estimates confirmation: 2019/05/17
Last earnings filing: 2019/05/14
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.